Filing Details

Accession Number:
0001236368-14-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-26 18:18:15
Reporting Period:
2014-02-26
Filing Date:
2014-02-26
Accepted Time:
2014-02-26 18:18:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236368 Phd Walter Gilbert 320 Wakara Way
Salt Lake City UT 84108
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-26 30,000 $24.40 30,000 No 4 M Direct
Common Stock Disposition 2014-02-26 30,000 $37.58 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-26 30,000 $0.00 30,000 $24.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-11-05 2019-11-05 No 4 M Direct
Footnotes
  1. Options vest in full upon completion of one full year of service, generally on the earlier of the first anniversary of the date of grant or the date of the next annual meeting of stockholders.